News Lilly offers AI discovery models to biotech partners Eli Lilly is offering AI-powered drug discovery models developed at a cost of around $1 billion to biotech companies for free.
News Survey reveals 'trust gap' in the value of AI to cardiology It seems cardiologists are more optimistic than patients about the potential of AI in helping cardiac teams improve care and save lives.
News Novartis taps Atropos AI for earlier PNH diagnoses Novartis teams up with real-world evidence specialist Atropos Health, hoping to speed up the diagnosis and treatment of rare disease PNH.
Digital Bridging domains: The untapped potential of AI-driven assess... The progression of artificial intelligence in healthcare has largely occurred in silos, with innovations developing within specific medical domains, rather than across them.
News AI could lead to 'golden age' of antibiotics Generative artificial intelligence could hold the key to turning back the rising tide of antimicrobial resistance, say MIT researchers.
News Novo Nordisk fight with KBP Bio will go to arbitration Singapore court keeps an asset freeze on KBP Bio, saying the merits of its dispute with Novo Nordisk over a licensing deal must go to arbitration.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
